Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation

Transplant Immunology

Volumn 25, Issue 1, 2011, Pages 1-6

  Tanabe, Tatsu ^a   Ishida, Hideki ^a   Horita, Shigeru ^a   Yamaguchi, Yutaka ^a,b   Toma, Hiroshi ^c   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Yamaguchi Pathological Research Institute   (Japan)

^c Department of Otolaryngology   (Japan)

Author keywords

ABO incompatible kidney transplantation; Antigenicity; Chimerism; Chronic antibody mediated rejection; Endothelial cell

Indexed keywords

BLOOD GROUP A ANTIBODY; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIBODY; BLOOD GROUP B ANTIGEN;

ADULT; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; CASE REPORT; CHIMERA; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ABO BLOOD-GROUP SYSTEM; ADULT; ENDOTHELIUM; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959683332     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.05.002     Document Type: Article

References (29)

1. Toki D., Ishida H., Setoguchi K., et al. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009, 9:567-577.
2. Ishida H., Miyamoto N., Shirakawa H., et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007, 7:825-831.
3. Takahashi K., Saito K. Present status of ABO-incompatible kidney transplantation in Japan. Xenotransplantation 2006, 13:118-122.
4. Aita K., Yamaguchi Y., Horita S., et al. Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts. Am J Transplant 2007, 7:923-929.
5. Haas M., Rahman M.H., Racusen L.C., et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings. Am J Transplant 2006, 6:1829-1840.
6. Kanetsuna Y., Yamaguchi Y., Horita S., Tanabe K., Toma H. C4d and/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation. Clin Transplant 2004, 18(Suppl 11):13-17.
7. Solez K., Colvin R., Racusen L., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
8. Ishii Y., Sawada T., Kubota K., Fuchinoue S., Teraoka S., Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int 2005, 67:321-332.
9. Tanabe K. Japanese experience of ABO-incompatible living kidney transplantation. Transplantation 2007, 84:S4-S7.
10. Chopek M.W., Simmons R.L., Platt J.L. ABO-incompatible kidney transplantation: initial immunopathologic evaluation. Transplant Proc 1987, 19:4553-4557.
11. Platt, Vercellotti, Dalmasso, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990, 11:450-456.
12. Koch C.A., Khalpey Z.I., Platt J.L. Accommodation: preventing injury in transplantation and disease. J Immunol 2004, 172:5143-5148.
13. Parker W., Holzknecht Z.E., Song A., et al. Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation. Am J Pathol 1998, 152:829-839.
14. Busso, Huet, Nicodème, Hiernaux, Hyafil Refractory period phenomenon in the induction of tissue factor expression on endothelial cells. Blood 1991, 78:2027-2035.
15. Murata K., Baldwin W.M. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) 2009, 23:139-150.
16. Koestner S., Kappeler A., Schaffner T., Carrel T., Nydegger U., Mohacsi P. Histo-blood group type change of the graft from B to O after ABO mismatched heart transplantation. Lancet 2004, 363:1523-1525.
17. West L.J., Pollock-Barziv S.M., Lee K.J., Dipchand A.I., Coles J.G., Ruiz P. Graft accommodation in infant recipients of ABO-incompatible heart transplants: donor ABH antigen expression in graft biopsies. J Heart Lung Transplant 2001, 20:222.
18. Breimer M.E., Mölne J., Nordén G., Rydberg L., Thiel G., Svalander C.T. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006, 82:479-485.
19. Yoshida A., Davè V., Hamilton H.B. Imbalance of blood group A subtypes and the existence of superactive B gene in Japanese in Hiroshima and Nagasaki. Am J Hum Genet 1988, 43:422-428.
20. Medawar P. Transplantation of tissues and organs: introduction 1965, 97. 21.
21. Lagaaij E., Cramer-Knijnenburg G., van Kemenade F., van Es L., Bruijn J., van Krieken J. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001, 357:33-37.
22. Ferlicot S., Vernochet A., Romana S., et al. Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells. Histopathology 2010, 56:188-197.
23. Popa E.R., Kas-Deelen A.M., Hepkema B.G., Van Son W.J., The T.H., Harmsen M.C. Donor-derived circulating endothelial cells after kidney transplantation. Transplantation 2002, 74:1320-1327.
24. van Poelgeest E., Baelde H., Lagaaij E., et al. Endothelial cell chimerism occurs more often and earlier in female than in male recipients of kidney transplants. Kidney Int 2005, 68:847-853.
25. Rienstra H., Boersema M., Onuta G., et al. Donor and recipient origin of mesenchymal and endothelial cells in chronic renal allograft remodeling. Am J Transplant 2009, 9:463-472.
26. Kwon O., Miller S., Li N., Khan A., Kadry Z., Uemura T. Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion. J Histochem Cytochem 2010, 58:687-694.
27. Taylor R.P., Lindorfer M.A. Impact of low-dose rituximab on splenic B cells: evidence for the shaving reaction. Transpl Int 2010, 23:116-117.
28. Li Y., Williams M.E., Cousar J.B., Pawluczkowycz A.W., Lindorfer M.A., Taylor R.P. Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models. J Immunol 2007, 179:4263-4271.
29. Tasaki M., Nakajima T., Imai N., et al. Detection of allogeneic blood group A and B enzyme activities in patients with ABO incompatible kidney transplantation. Glycobiology 2010, 20:1251-1258.